Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis
Breast cancer: Trapping tumors in place Drugs that inhibit two protein-digesting enzymes could offer potent protection against tumor growth and metastasis in an aggressive form of breast cancer. “Triple-negative breast cancer” (TNBC), which lacks three common tumor biomarkers, carries a poor prognos...
Main Authors: | Jaya Gautam, Suhrid Banskota, Hyunji Lee, Yu-Jeong Lee, Yong Hyun Jeon, Jung-Ae Kim, Byeong-Seon Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-09-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-018-0135-9 |
Similar Items
-
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
by: Lamar, John, et al.
Published: (2020) -
Nuclear Functions of the Tyrosine Kinase Src
by: Giulia Bagnato, et al.
Published: (2020-04-01) -
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
by: Roman Bandurski, et al.
Published: (2008-02-01) -
BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.
by: Suhrid Banskota, et al.
Published: (2016-01-01) -
Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease
by: Chhabi Lal Chaudhary, et al.
Published: (2020-01-01)